Brown, Lisle/Cummings’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
PCM
AA
Brown, Lisle/Cummings's OGN Position: Q2 2026 in Review
Brown, Lisle/Cummings reduced its Organon & Co (OGN) stake by 12% in Q2 2026, selling an estimated $5.98K and leaving 3,643 shares worth $49.3K. The position accounts for 0.01% of the portfolio, ranked #397.
Brown, Lisle/Cummings first reported a position in OGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $953K in Q2 2022. 633 funds tracked by Wall St. Rank hold OGN as of Q2 2026.
- Brown, Lisle/Cummings held 3,643 shares of Organon & Co worth $49.3K as of Q2 2026.
- Brown, Lisle/Cummings sold 500 Organon & Co shares in Q2 2026, an estimated $5.98K.
- Organon & Co made up 0.01% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #397 holding.
- Brown, Lisle/Cummings first reported a position in Organon & Co in Q4 2021 and has held it in 19 quarters since.
- Brown, Lisle/Cummings's Organon & Co position peaked at $953K in Q2 2022.
- 633 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.
Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.